Advertisement
Singapore markets closed

  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • Dow

    38,239.98
    +253.58 (+0.67%)
     

  • Nasdaq

    15,451.31
    +169.30 (+1.11%)
     

  • Bitcoin USD

    66,130.97
    +169.18 (+0.26%)
     

  • CMC Crypto 200

    1,420.33
    +5.57 (+0.39%)
     

  • FTSE 100

    8,040.65
    +16.78 (+0.21%)
     

  • Gold

    2,316.50
    -29.90 (-1.27%)
     

  • Crude Oil

    81.20
    -0.70 (-0.85%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     

  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     

  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     

  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     

  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Finnish drugmaker Orion's third-quarter profit and sales fall

Reuters
·1-min read

HELSINKI (Reuters) - Finnish drugmaker Orion on Wednesday reported a drop in quarterly profit and sales, after raising its full-year outlook a day earlier, helped by higher sales of its sedative Dexdor in March and April.

Orion's operating profit in the quarter fell 28% from a year earlier to 65.1 million euros ($77.1 million) on sales down nearly 12% to 250.3 million euros.

On Tuesday, Orion said it expects its 2020 operating profit to be higher or clearly higher than in 2019, compared to a June forecast of slightly higher or higher.

($1 = 0.8440 euros)

(Reporting by Anne Kauranen, editing by Louise Heavens)